{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:52:12Z","timestamp":1792234332409,"version":"4.4.0"},"reference-count":103,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1213\/ane.0b013e3181b845d0","type":"journal-article","created":{"date-parts":[[2009,11,16]],"date-time":"2009-11-16T03:14:58Z","timestamp":1258341298000},"page":"1949-1961","source":"Crossref","is-referenced-by-count":53,"title":["Perioperative Management of the Adult with Cystic Fibrosis"],"prefix":"10.1213","volume":"109","author":[{"given":"Julie L.","family":"Huffmyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith E.","family":"Littlewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Nemergut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-36-20210902","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1164\/rccm.200505-840OE","article-title":"Cystic fibrosis since 1938.","volume":"173","author":"Davis","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-36-20210902","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.298.15.1787","article-title":"Adult cystic fibrosis.","volume":"298","author":"Boyle","year":"2007","journal-title":"JAMA"},{"key":"R3-36-20210902","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1378\/chest.125.1_suppl.1S","article-title":"Cystic fibrosis adult care: consensus conference report.","volume":"125","author":"Yankaskas","year":"2004","journal-title":"Chest"},{"key":"R4-36-20210902","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/adc.2008.143578","article-title":"Cystic fibrosis and the transition to adult health services.","volume":"93","author":"Hewer","year":"2008","journal-title":"Arch Dis Child"},{"key":"R5-36-20210902","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"R6-36-20210902","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2772657","article-title":"Identification of the cystic fibrosis gene: chromosome walking and jumping.","volume":"245","author":"Rommens","year":"1989","journal-title":"Science"},{"key":"R7-36-20210902","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1569-1993(01)00003-0","article-title":"The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions.","volume":"1","author":"Vankeerberghen","year":"2002","journal-title":"J Cyst Fibros"},{"key":"R8-36-20210902","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0092-8674(93)90353-R","article-title":"Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis.","volume":"73","author":"Welsh","year":"1993","journal-title":"Cell"},{"key":"R9-36-20210902","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(03)12567-6","article-title":"Cystic fibrosis.","volume":"361","author":"Ratjen","year":"2003","journal-title":"Lancet"},{"key":"R10-36-20210902","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF00201659","article-title":"Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations.","volume":"93","author":"Dean","year":"1994","journal-title":"Hum Genet"},{"key":"R11-36-20210902","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1056\/NEJM199310283291804","article-title":"Correlation between genotype and phenotype in patients with cystic fibrosis. The Cystic Fibrosis Genotype-Phenotype Consortium.","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"R12-36-20210902","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1542\/peds.93.1.114","article-title":"Delta F508 genotype does not predict disease severity in an ethnically diverse cystic fibrosis population.","volume":"93","author":"Lester","year":"1994","journal-title":"Pediatrics"},{"key":"R13-36-20210902","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMoa051469","article-title":"Genetic modifiers of lung disease in cystic fibrosis.","volume":"353","author":"Drumm","year":"2005","journal-title":"N Engl J Med"},{"key":"R14-36-20210902","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1067\/mlc.2003.29","article-title":"Modifier genes in cystic fibrosis lung disease.","volume":"141","author":"Merlo","year":"2003","journal-title":"J Lab Clin Med"},{"key":"R15-36-20210902","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1164\/rccm.200412-1714OC","article-title":"Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism.","volume":"172","author":"Plant","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R16-36-20210902","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJM199009203231203","article-title":"Exposure of children with cystic fibrosis to environmental tobacco smoke.","volume":"323","author":"Rubin","year":"1990","journal-title":"N Engl J Med"},{"key":"R17-36-20210902","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/oxfordjournals.aje.a009172","article-title":"Gender gap in cystic fibrosis mortality.","volume":"145","author":"Rosenfeld","year":"1997","journal-title":"Am J Epidemiol"},{"key":"R18-36-20210902","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0895-4356(88)90063-7","article-title":"A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto.","volume":"41","author":"Corey","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"R19-36-20210902","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1164\/ajrccm.163.6.9912100","article-title":"The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States.","volume":"163","author":"Schechter","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R20-36-20210902","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-008-8080-3","article-title":"Gene therapy for cystic fibrosis.","volume":"35","author":"Mueller","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"R21-36-20210902","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.GIM.0000139505.06194.39","article-title":"Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population.","volume":"6","author":"Palomaki","year":"2004","journal-title":"Genet Med"},{"key":"R22-36-20210902","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis.","volume":"168","author":"Gibson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 3","key":"R23-36-20210902","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis\u2014state of the art: Cystic Fibrosis Foundation Consensus Conference.","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R24-36-20210902","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1378\/chest.130.1.222","article-title":"Aspergillus bronchitis in cystic fibrosis.","volume":"130","author":"Shoseyov","year":"2006","journal-title":"Chest"},{"key":"R25-36-20210902","first-page":"1075","article-title":"Early pulmonary inflammation in infants with cystic fibrosis.","volume":"151","author":"Khan","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"R26-36-20210902","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1165\/ajrcmb.23.2.4214","article-title":"Inflammation and infection in naive human cystic fibrosis airway grafts.","volume":"23","author":"Tirouvanziam","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R27-36-20210902","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1165\/ajrcmb.13.3.7544594","article-title":"Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis.","volume":"13","author":"Bonfield","year":"1995","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R28-36-20210902","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1073\/pnas.92.7.3019","article-title":"Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface [erratum appears in Proc Natl Acad Sci USA 1995;92:11322].","volume":"92","author":"Imundo","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"R29-36-20210902","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0092-8674(00)81099-5","article-title":"Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid [erratum appears in Cell 1996;87: following 355].","volume":"85","author":"Smith","year":"1996","journal-title":"Cell"},{"key":"R30-36-20210902","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1172\/JCI0213870","article-title":"Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients.","volume":"109","author":"Worlitzsch","year":"2002","journal-title":"J Clin Invest"},{"key":"R31-36-20210902","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1378\/chest.128.2.720","article-title":"Pneumothorax in cystic fibrosis.","volume":"128","author":"Flume","year":"2005","journal-title":"Chest"},{"key":"R32-36-20210902","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1378\/chest.123.1.217","article-title":"Pneumothorax in cystic fibrosis.","volume":"123","author":"Flume","year":"2003","journal-title":"Chest"},{"issue":"suppl 41","key":"R33-36-20210902","first-page":"2","article-title":"The heart in cystic fibrosis.","volume":"95","author":"Bright-Thomas","year":"2002","journal-title":"J R Soc Med"},{"key":"R34-36-20210902","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1378\/chest.115.5.1321","article-title":"Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia.","volume":"115","author":"Fraser","year":"1999","journal-title":"Chest"},{"key":"R35-36-20210902","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ppul.1950030307","article-title":"Effect of oxygen on right ventricular performance evaluated by radionuclide angiography in two young patients with chronic lung disease.","volume":"3","author":"Alpert","year":"1987","journal-title":"Pediatr Pulmonol"},{"key":"R36-36-20210902","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1164\/rccm.200410-1369OC","article-title":"Risk factors for death of patients with cystic fibrosis awaiting lung transplantation.","volume":"173","author":"Belkin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R37-36-20210902","doi-asserted-by":"crossref","first-page":"124S","DOI":"10.1378\/chest.120.3_suppl.124S","article-title":"Gene therapy in cystic fibrosis.","volume":"120","author":"Flotte","year":"2001","journal-title":"Chest"},{"key":"R38-36-20210902","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.","volume":"340","author":"Ramsey","year":"1999","journal-title":"N Engl J Med"},{"key":"R39-36-20210902","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1378\/chest.128.4.2327","article-title":"Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysis.","volume":"128","author":"Robinson","year":"2005","journal-title":"Chest"},{"key":"R40-36-20210902","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.","volume":"331","author":"Fuchs","year":"1994","journal-title":"N Engl J Med"},{"key":"R41-36-20210902","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.","volume":"354","author":"Elkins","year":"2006","journal-title":"N Engl J Med"},{"key":"R42-36-20210902","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00151829-200504040-00004","article-title":"Anti-inflammatory medications for cystic fibrosis lung disease: selecting the most appropriate agent.","volume":"4","author":"Chmiel","year":"2005","journal-title":"Treat Respir Med"},{"key":"R43-36-20210902","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.prrv.2008.04.003","article-title":"Nasal and sinus disease in cystic fibrosis.","volume":"9","author":"Robertson","year":"2008","journal-title":"Paediatr Respir Rev"},{"key":"R44-36-20210902","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/1099-0496(200012)30:6<481::AID-PPUL8>3.0.CO;2-N","article-title":"Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management.","volume":"30","author":"Gysin","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"R45-36-20210902","first-page":"1067","article-title":"Treatment and prognosis of nasal polyps in cystic fibrosis.","volume":"136","author":"Stern","year":"1982","journal-title":"Am J Dis Child"},{"key":"R46-36-20210902","first-page":"155","article-title":"The ultrastructure of the nasal polyps in patients with and without cystic fibrosis.","volume":"36","author":"Beju","year":"2004","journal-title":"J Submicrosc Cytol Pathol"},{"key":"R47-36-20210902","first-page":"445","article-title":"Differential pathology of nasal polyps in cystic fibrosis and atopy.","volume":"40","author":"Oppenheimer","year":"1979","journal-title":"Lab Invest"},{"key":"R48-36-20210902","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2222.2005.02215.x","article-title":"Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators.","volume":"35","author":"Claeys","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"R49-36-20210902","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/00005537-199608000-00018","article-title":"Patterns of sinusitis in cystic fibrosis.","volume":"106","author":"Gentile","year":"1996","journal-title":"Laryngoscope"},{"key":"R50-36-20210902","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/thx.2004.039842","article-title":"Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis.","volume":"61","author":"Roca-Ferrer","year":"2006","journal-title":"Thorax"},{"key":"R51-36-20210902","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02914539","article-title":"Upper respiratory disease, sinusitis, and polyposis.","volume":"9","author":"King","year":"1991","journal-title":"Clin Rev Allergy"},{"key":"R52-36-20210902","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archotol.131.12.1097","article-title":"Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease.","volume":"131","author":"Cimmino","year":"2005","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R53-36-20210902","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.otohns.2005.03.064","article-title":"Sinonasal posttransplant lymphoproliferative disorder in pediatric lung transplant patients.","volume":"133","author":"Herrmann","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R54-36-20210902","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198502073120601","article-title":"Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis.","volume":"312","author":"Kopelman","year":"1985","journal-title":"N Engl J Med"},{"key":"R55-36-20210902","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1542\/peds.2004-1242","article-title":"Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover.","volume":"115","author":"Conway","year":"2005","journal-title":"Pediatrics"},{"key":"R56-36-20210902","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-3476(05)83042-2","article-title":"The cystic fibrosis gene and resting energy expenditure.","volume":"119","author":"Fried","year":"1991","journal-title":"J Pediatr"},{"key":"R57-36-20210902","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0168-8227(99)00058-3","article-title":"Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report.","volume":"45","author":"Moran","year":"1999","journal-title":"Diabetes Res Clin Pract"},{"key":"R58-36-20210902","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1262-3636(07)70189-1","article-title":"Diabetes: a major co-morbidity of cystic fibrosis.","volume":"31","author":"Costa","year":"2005","journal-title":"Diabetes Metab"},{"key":"R59-36-20210902","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00005176-199708000-00010","article-title":"Insulin resistance with altered secretory kinetics and reduced proinsulin in cystic fibrosis patients.","volume":"25","author":"Holl","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R60-36-20210902","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005176-199900001-00001","article-title":"Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group.","volume":"28(suppl 1)","author":"Sokol","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R61-36-20210902","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome.","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"key":"R62-36-20210902","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/00042737-200510000-00018","article-title":"Advanced hepatocellular carcinoma associated with cystic fibrosis.","volume":"17","author":"Kelleher","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R63-36-20210902","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00006676-200105000-00010","article-title":"Gastrointestinal, liver, and pancreatic involvement in adult patients with cystic fibrosis.","volume":"22","author":"Modolell","year":"2001","journal-title":"Pancreas"},{"key":"R64-36-20210902","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.1840150418","article-title":"Genotype analysis for delta F508, G551D and R553X mutations in children and young adults with cystic fibrosis with and without chronic liver disease.","volume":"15","author":"Duthie","year":"1992","journal-title":"Hepatology"},{"key":"R65-36-20210902","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0168-8278(95)80058-1","article-title":"The major histocompatibility complex influences the development of chronic liver disease in male children and young adults with cystic fibrosis.","volume":"23","author":"Duthie","year":"1995","journal-title":"J Hepatology"},{"key":"R66-36-20210902","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/jhep.2002.35534","article-title":"Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism.","volume":"36","author":"Henrion-Caude","year":"2002","journal-title":"Hepatology"},{"key":"R67-36-20210902","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/clpt.1988.147","article-title":"Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease.","volume":"44","author":"Knoppert","year":"1988","journal-title":"Clin Pharmacol Ther"},{"key":"R68-36-20210902","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0022-3476(05)80149-0","article-title":"Enhanced hepatic drug clearance in patients with cystic fibrosis.","volume":"117","author":"Kearns","year":"1990","journal-title":"J of Pediatrics"},{"key":"R69-36-20210902","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1542-3565(04)00169-7","article-title":"Distal intestinal obstruction syndrome in adults with cystic fibrosis.","volume":"2","author":"Dray","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R70-36-20210902","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0022-3468(99)90110-0","article-title":"Intestinal obstruction after lung transplantation in children with cystic fibrosis.","volume":"34","author":"Minkes","year":"1999","journal-title":"J Pediatr Surg"},{"key":"R71-36-20210902","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.123.1.37","article-title":"GI complications after lung transplantation in patients with cystic fibrosis.","volume":"123","author":"Gilljam","year":"2003","journal-title":"Chest"},{"key":"R72-36-20210902","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/jc.2004-1629","article-title":"Guide to bone health and disease in cystic fibrosis.","volume":"90","author":"Aris","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R73-36-20210902","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/adc.84.4.363","article-title":"Normal bone mineral density in cystic fibrosis.","volume":"84","author":"Hardin","year":"2001","journal-title":"Arch Dis Child"},{"key":"R74-36-20210902","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-128-3-199802010-00004","article-title":"Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis.","volume":"128","author":"Aris","year":"1998","journal-title":"Ann Intern Med"},{"key":"R75-36-20210902","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0022-3476(94)70194-6","article-title":"Kyphosis and fractures in children and young adults with cystic fibrosis.","volume":"125","author":"Henderson","year":"1994","journal-title":"J Pediatr"},{"key":"R76-36-20210902","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1515\/JPEM.2005.18.6.589","article-title":"Growth hormone improves bone mineral content in children with cystic fibrosis.","volume":"18","author":"Hardin","year":"2005","journal-title":"J Pediatr Endocrinol"},{"key":"R77-36-20210902","first-page":"CD002010","article-title":"Bisphosphonates for osteoporosis in people with cystic fibrosis.","author":"Brenckmann","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"R78-36-20210902","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00063198-200111000-00011","article-title":"Infertility in men with cystic fibrosis.","volume":"7","author":"Sokol","year":"2001","journal-title":"Curr Opin Pulm Med"},{"key":"R79-36-20210902","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/thorax.56.8.649","article-title":"Women with cystic fibrosis and their potential for reproduction.","volume":"56","author":"Edenborough","year":"2001","journal-title":"Thorax"},{"key":"R80-36-20210902","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.mcg.0000155140.63510.cd","article-title":"Cystic fibrosis: an overview.","volume":"39","author":"Turcios","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"R81-36-20210902","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1378\/chest.104.5.1490","article-title":"Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis.","volume":"104","author":"Sawyer","year":"1993","journal-title":"Chest"},{"key":"R82-36-20210902","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1183\/09031936.04.00142903","article-title":"HRCT lung abnormalities are not a surrogate for exercise limitation in bronchiectasis.","volume":"24","author":"Edwards","year":"2004","journal-title":"Eur Respir J"},{"key":"R83-36-20210902","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpeds.2007.03.006","article-title":"Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.","volume":"151","author":"Konstan","year":"2007","journal-title":"J Pediatr"},{"key":"R84-36-20210902","first-page":"779","article-title":"Slow-rate, high-pressure ventilation: a method of management of difficult transplant recipients during sequential double lung transplantation for cystic fibrosis.","volume":"13","author":"Robinson","year":"1994","journal-title":"J Heart Lung Transplant"},{"key":"R85-36-20210902","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1213\/01.ANE.0000104582.71710.EE","article-title":"Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery.","volume":"98","author":"Koppert","year":"2004","journal-title":"Anesth Analg"},{"key":"R86-36-20210902","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1213\/ane.0b013e3181732776","article-title":"Postoperative ketamine administration decreases morphine consumption in major abdominal surgery: a prospective, randomized, double-blind, controlled study.","volume":"106","author":"Zakine","year":"2008","journal-title":"Anesth Analg"},{"key":"R87-36-20210902","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00540-006-0425-6","article-title":"Epidural anesthesia and pulmonary function.","volume":"20","author":"Groeben","year":"2006","journal-title":"J Anesth"},{"key":"R88-36-20210902","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1136\/bmj.321.7275.1493","article-title":"Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials.","volume":"321","author":"Rodgers","year":"2000","journal-title":"BMJ"},{"key":"R89-36-20210902","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.healun.2007.06.003","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007.","volume":"26","author":"Trulock","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R90-36-20210902","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1378\/chest.113.1.217","article-title":"Lung transplantation in cystic fibrosis: consensus conference statement.","volume":"113","author":"Yankaskas","year":"1998","journal-title":"Chest"},{"key":"R91-36-20210902","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1001\/jama.286.21.2683","article-title":"Survival effect of lung transplantation among patients with cystic fibrosis.","volume":"286","author":"Liou","year":"2001","journal-title":"JAMA"},{"key":"R92-36-20210902","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/thx.2007.092056","article-title":"Outcomes of lung transplantation for cystic fibrosis in a large UK cohort.","volume":"63","author":"Meachery","year":"2008","journal-title":"Thorax"},{"key":"R93-36-20210902","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.healun.2008.11.903","article-title":"Lung transplantation in older patients with cystic fibrosis: analysis of UNOS data.","volume":"28","author":"Weiss","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R94-36-20210902","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jtcvs.2005.10.050","article-title":"Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung.","volume":"131","author":"Fischer","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R95-36-20210902","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0022-3476(95)70022-6","article-title":"Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosis.","volume":"127","author":"Mack","year":"1995","journal-title":"J Pediatr"},{"key":"R96-36-20210902","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00595-007-3576-7","article-title":"Liver transplantation for cystic fibrosis in adults.","volume":"38","author":"Ikegami","year":"2008","journal-title":"Surg Today"},{"key":"R97-36-20210902","first-page":"391","article-title":"Respiratory diseases in pregnancy.","volume":"15","author":"Noble","year":"1988","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R98-36-20210902","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0272-5231(21)01125-4","article-title":"Respiratory physiology in pregnancy.","volume":"13","author":"Elkus","year":"1992","journal-title":"Clin Chest Med"},{"key":"R99-36-20210902","first-page":"809","article-title":"Cystic fibrosis in pregnancy.","volume":"149","author":"Kent","year":"1993","journal-title":"CMAJ"},{"key":"R100-36-20210902","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1378\/chest.118.1.85","article-title":"Pregnancy in cystic fibrosis. Fetal and maternal outcome.","volume":"118","author":"Gilljam","year":"2000","journal-title":"Chest"},{"key":"R101-36-20210902","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijoa.2004.08.003","article-title":"Caesarean section in a patient with cystic fibrosis.","volume":"14","author":"Muammar","year":"2005","journal-title":"Int J Obstet Anesth"},{"key":"R102-36-20210902","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2222.1997.132-az0128.x","article-title":"Caesarean section in a parturient with respiratory failure caused by cystic fibrosis.","volume":"52","author":"Bose","year":"1997","journal-title":"Anaesthesia"},{"key":"R103-36-20210902","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1164\/rccm.200605-598OE","article-title":"Pregnancy and chronic progressive pulmonary disease.","volume":"175","author":"Wexler","year":"2007","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0b013e3181b845d0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:34:58Z","timestamp":1786113298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-200912000-00036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":103,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3181b845d0","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}